NVAX logo

Novavax (NVAX) Accounts payable

annual accounts payable:

$41.58M-$91.03M(-68.65%)
December 31, 2024

Summary

  • As of today (May 21, 2025), NVAX annual accounts payable is $41.58 million, with the most recent change of -$91.03 million (-68.65%) on December 31, 2024.
  • During the last 3 years, NVAX annual accounts payable has fallen by -$85.47 million (-67.27%).
  • NVAX annual accounts payable is now -80.80% below its all-time high of $216.52 million, reached on December 31, 2022.

Performance

NVAX Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXbalance sheet metrics

quarterly accounts payable:

$34.16M-$7.42M(-17.84%)
March 31, 2025

Summary

  • As of today (May 21, 2025), NVAX quarterly accounts payable is $34.16 million, with the most recent change of -$7.42 million (-17.84%) on March 31, 2025.
  • Over the past year, NVAX quarterly accounts payable has dropped by -$23.56 million (-40.82%).
  • NVAX quarterly accounts payable is now -91.16% below its all-time high of $386.49 million, reached on June 30, 2022.

Performance

NVAX quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

NVAX Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-68.7%-40.8%
3 y3 years-67.3%-74.7%
5 y5 years+1328.8%+1256.7%

NVAX Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-80.8%at low-91.2%at low
5 y5-year-80.8%+1328.8%-91.2%+1256.7%
alltimeall time-80.8%>+9999.0%-91.2%>+9999.0%

NVAX Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$34.16M(-17.8%)
Dec 2024
$41.58M(-68.6%)
$41.58M(-27.7%)
Sep 2024
-
$57.52M(-28.1%)
Jun 2024
-
$79.96M(+38.5%)
Mar 2024
-
$57.72M(-56.5%)
Dec 2023
$132.61M(-38.8%)
$132.61M(+30.1%)
Sep 2023
-
$101.91M(+16.8%)
Jun 2023
-
$87.25M(-30.1%)
Mar 2023
-
$124.80M(-42.4%)
Dec 2022
$216.52M(+70.4%)
$216.52M(+49.3%)
Sep 2022
-
$145.00M(-62.5%)
Jun 2022
-
$386.49M(+186.0%)
Mar 2022
-
$135.13M(+6.4%)
Dec 2021
$127.05M(+133.8%)
$127.05M(+113.3%)
Sep 2021
-
$59.56M(-19.5%)
Jun 2021
-
$74.00M(-34.9%)
Mar 2021
-
$113.61M(+109.1%)
Dec 2020
$54.33M(+1767.1%)
$54.33M(+259.9%)
Sep 2020
-
$15.10M(+63.4%)
Jun 2020
-
$9.24M(+267.0%)
Mar 2020
-
$2.52M(-13.5%)
Dec 2019
$2.91M(-68.7%)
$2.91M(-30.9%)
Sep 2019
-
$4.21M(-2.2%)
Jun 2019
-
$4.30M(-30.0%)
Mar 2019
-
$6.15M(-33.9%)
Dec 2018
$9.30M(+65.7%)
$9.30M(+37.0%)
Sep 2018
-
$6.79M(+1.6%)
Jun 2018
-
$6.69M(+15.9%)
Mar 2018
-
$5.77M(+2.8%)
Dec 2017
$5.61M(-1.3%)
$5.61M(+7.1%)
Sep 2017
-
$5.24M(-34.6%)
Jun 2017
-
$8.02M(+111.6%)
Mar 2017
-
$3.79M(-33.3%)
Dec 2016
$5.68M(-52.2%)
$5.68M(-65.0%)
Sep 2016
-
$16.23M(+1.5%)
Jun 2016
-
$15.99M(+42.3%)
Mar 2016
-
$11.24M(-5.5%)
Dec 2015
$11.89M(-7.9%)
$11.89M(+45.0%)
Sep 2015
-
$8.20M(+15.2%)
Jun 2015
-
$7.12M(-26.9%)
Mar 2015
-
$9.74M(-24.5%)
Dec 2014
$12.91M(+115.7%)
$12.91M(+333.9%)
Sep 2014
-
$2.98M(-33.8%)
Jun 2014
-
$4.50M(+11.9%)
Mar 2014
-
$4.02M(-32.9%)
Dec 2013
$5.99M(+85.4%)
$5.99M(+79.2%)
Sep 2013
-
$3.34M(+13.3%)
Jun 2013
-
$2.95M(+35.6%)
Mar 2013
-
$2.17M(-32.7%)
Dec 2012
$3.23M(+22.0%)
$3.23M(+46.5%)
Sep 2012
-
$2.20M(-34.8%)
Jun 2012
-
$3.38M(+14.2%)
Mar 2012
-
$2.96M(+11.9%)
Dec 2011
$2.65M(-26.0%)
$2.65M(+10.4%)
Sep 2011
-
$2.40M(-19.1%)
Jun 2011
-
$2.96M(-11.9%)
Mar 2011
-
$3.36M(-5.9%)
Dec 2010
$3.57M
$3.57M(+6.6%)
DateAnnualQuarterly
Sep 2010
-
$3.35M(-2.4%)
Jun 2010
-
$3.43M(-37.3%)
Mar 2010
-
$5.47M(+160.9%)
Dec 2009
$2.10M(+19.9%)
$2.10M(+35.9%)
Sep 2009
-
$1.54M(+5.8%)
Jun 2009
-
$1.46M(+42.6%)
Mar 2009
-
$1.02M(-41.5%)
Dec 2008
$1.75M(+17.4%)
$1.75M(-11.0%)
Sep 2008
-
$1.97M(+169.8%)
Jun 2008
-
$729.00K(-66.7%)
Mar 2008
-
$2.19M(+46.7%)
Dec 2007
$1.49M(-2.6%)
$1.49M(-36.8%)
Sep 2007
-
$2.36M(-4.8%)
Jun 2007
-
$2.48M(+40.5%)
Mar 2007
-
$1.76M(+15.3%)
Dec 2006
$1.53M(+7.3%)
$1.53M(+73.1%)
Sep 2006
-
$884.00K(+13.3%)
Jun 2006
-
$780.00K(-3.8%)
Mar 2006
-
$811.00K(-43.1%)
Dec 2005
$1.43M(-56.0%)
$1.43M(+89.4%)
Sep 2005
-
$753.00K(-38.8%)
Jun 2005
-
$1.23M(-19.0%)
Mar 2005
-
$1.52M(-53.2%)
Dec 2004
$3.24M(+38.4%)
$3.24M(-21.2%)
Sep 2004
-
$4.11M(+1.4%)
Jun 2004
-
$4.06M(+71.7%)
Mar 2004
-
$2.36M(+0.9%)
Dec 2003
$2.34M(-7.6%)
$2.34M(+6.4%)
Sep 2003
-
$2.20M(+29.9%)
Jun 2003
-
$1.69M(+5.9%)
Mar 2003
-
$1.60M(-36.9%)
Dec 2002
$2.53M(+79.7%)
$2.53M(-1.9%)
Sep 2002
-
$2.58M(-40.2%)
Jun 2002
-
$4.32M(+136.5%)
Mar 2002
-
$1.83M(+29.5%)
Dec 2001
$1.41M(+0.6%)
$1.41M(-4.9%)
Sep 2001
-
$1.48M(-2.5%)
Jun 2001
-
$1.52M(+45.1%)
Mar 2001
-
$1.05M(-25.2%)
Dec 2000
$1.40M(+180.2%)
$1.40M(-27.2%)
Sep 2000
-
$1.93M(+46.8%)
Jun 2000
-
$1.31M(+113.5%)
Mar 2000
-
$614.00K(+22.8%)
Dec 1999
$500.00K(-37.5%)
$500.00K(-28.6%)
Sep 1999
-
$700.00K(+250.0%)
Jun 1999
-
$200.00K(-75.0%)
Mar 1999
-
$800.00K(0.0%)
Dec 1998
$800.00K(+300.0%)
$800.00K(+700.0%)
Sep 1998
-
$100.00K(-50.0%)
Jun 1998
-
$200.00K(0.0%)
Mar 1998
-
$200.00K(0.0%)
Dec 1997
$200.00K(-50.0%)
$200.00K(+100.0%)
Sep 1997
-
$100.00K(-66.7%)
Jun 1997
-
$300.00K(0.0%)
Mar 1997
-
$300.00K(-25.0%)
Dec 1996
$400.00K
$400.00K(+33.3%)
Sep 1996
-
$300.00K(-25.0%)
Jun 1996
-
$400.00K(0.0%)
Mar 1996
-
$400.00K

FAQ

  • What is Novavax annual accounts payable?
  • What is the all time high annual accounts payable for Novavax?
  • What is Novavax annual accounts payable year-on-year change?
  • What is Novavax quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Novavax?
  • What is Novavax quarterly accounts payable year-on-year change?

What is Novavax annual accounts payable?

The current annual accounts payable of NVAX is $41.58M

What is the all time high annual accounts payable for Novavax?

Novavax all-time high annual accounts payable is $216.52M

What is Novavax annual accounts payable year-on-year change?

Over the past year, NVAX annual accounts payable has changed by -$91.03M (-68.65%)

What is Novavax quarterly accounts payable?

The current quarterly accounts payable of NVAX is $34.16M

What is the all time high quarterly accounts payable for Novavax?

Novavax all-time high quarterly accounts payable is $386.49M

What is Novavax quarterly accounts payable year-on-year change?

Over the past year, NVAX quarterly accounts payable has changed by -$23.56M (-40.82%)
On this page